Avidity Biosciences Inc - RNA Profit before interest, taxes and amortization
Avidity Biosciences (RNA) pilot RNA-based drug production capacities are operating in preparation for testing, which correlates with the trend in EBITDA. The value of 0.00 serves as the current indicator of this curve. Future revenue is based on therapy for rare myopathies, however, the business is constrained by a lack of sales, strict FDA oversight, and rapid capital burn during early-stage research.
Summary analytical data breakdowns for Avidity Biosciences, Inc. (RNA)
- current price and projected stock value:
- issuer market value details:
- book capitalization data:
- company total debt and liquidity indicators:
Total Debt to Capital Coefficient Avidity Biosciences|RNA - Long-Term Debt to Equity|Current Liabilities to Capital Avidity Biosciences Inc|RNA - Company Debts|Debts to Net Assets Avidity Biosciences|RNA - Company Long-Term Debts|Company Current Liabilities Avidity Biosciences|Interim Coverage Ratio aviditybiosciences.com
- earnings and market ratios statistics:
RNA - Net Profit|Expected Net Profit Avidity Biosciences|RNA - Price to Earnings Ratio|Price to Future Earnings Ratio aviditybiosciences.com|RNA - PEG Multiple|Enterprise Value to EBITDA Ratio Avidity Biosciences|RNA - Operating profit EBITDA|Net earnings per one share for the last twelve months Avidity Biosciences|RNA - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months aviditybiosciences.com|RNA - Earnings per share growth in current year|Expected earnings per share trend next year Avidity Biosciences
Analysis of all company metrics:RNA Avidity Corp
This indicator captures real cash flow from core operations, excluding non-cash depreciation and GAAP accounting adjustments to assess true liquidity. Analyzing the EBITDA of Avidity Biosciences (RNA) allows for monitoring the capital burn rate, which is critical for Avidity Biosciences (RNA), as its RNA-based drugs are currently in the development stage and do not yet generate commercial revenue.
Who Avidity Biosciences competes with
Company profit before taxes, interest and amortization TEM (Tempus)|QGEN: Operating profit before deduction of amortization|Profit before interest, taxes and amortization ionispharma.com|RGEN (Repligen) - Operating profit before deduction of amortization|CRISPR Therapeutics Inc - Income before deduction of interest, taxes and amortization|WGS (Sema4) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization RARE|Operating profit EBITDA BEAM|Operating income before deduction of amortization sarepta.com|Profit before payment of interest, taxes and amortization Twist Bioscience, Inc. TWST|10x Genomics Inc (TXG) - Profit before interest, taxes and amortization|NTLA - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Stoke Corp STOK|BLFS: Operating profit EBITDA|Operating profit before deduction of amortization wavelifesciences.com|MAZE (Maze Therapeutics) - Operating profit EBITDA|Sionna Therapeutics, Inc. (SION) - Operating income before deduction of amortization|Operating profit EBITDA PRME|TSHA - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization uniQure N.V. QURE|MGTX: Operating profit before amortization|REGENXBIO - Operating profit EBITDA|Solid Biosciences Inc (SLDB) - Operating profit before deduction of amortization|OCGN: Operating profit EBITDA|Profit before interest, taxes and amortization PacBio Corp (PACB)|Profit before payment of interest, taxes and amortization Benitec Biopharma Inc.|designtx.com (DSGN) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Rocket Pharmaceuticals, Inc. (RCKT)|FDMT (4DMT) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Lexeo Therapeutics, Inc. LXEO|KRRO: Operating profit before amortization|Editas Medicine, Inc. - Operating profit EBITDA|SLN - Operating profit EBITDA|PRQR: Operating profit EBITDA|Operating profit before amortization CDXS|Profit before payment of interest, taxes and amortization Sangamo|Operating profit before amortization NAUT (Nautilus Biotechnology Inc)|Operating profit EBITDA MGX|Operating profit EBITDA precisionbiosciences.com (DTIL)|Operating profit EBITDA GBIO (Generation Bio)|Operating profit EBITDA Boundless Bio Inc. BOLD|XCUR: Operating profit before deduction of amortization|IMNN: Profit before payment of interest, taxes and amortization|PHIO: Operating profit EBITDA|MBIO - Operating income before deduction of amortization|RNAZ (TransCode Therapeutics Inc.) - Operating profit EBITDA|Operating profit before amortization BNGO (Bionano)|Operating profit EBITDA APDN|Operating income before deduction of amortization bluebird bio, Inc|ImmunoPrecise Antibodies Ltd. - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization OMGA (omegatherapeutics.com)|OMIC: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Regulus Therapeutics, Inc.|SYRS (Syros) - Operating profit before deduction of amortization|Telesis Bio, Inc - Income before deduction of interest, taxes and amortization|TCON (TRACON Pharmaceuticals) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization UBX
